Of the FGFR2b-ligands, FGF1 was the most significantly increased in IPF patients; downstream targets of FGF-signaling, p-ERK1/2 and p-AKT were also increased. The gene discussed is AKT1; the disease is idiopathic pulmonary fibrosis.